140 related articles for article (PubMed ID: 19821956)
21. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
22. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience.
El-Husseini AA; Foda MA; Shokeir AA; Shehab El-Din AB; Sobh MA; Ghoneim MA
Pediatr Transplant; 2005 Dec; 9(6):763-9. PubMed ID: 16269048
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
24. Transplantation: impact of pretransplant renal insufficiency.
Bahirwani R; Campbell MS; Siropaides T; Markmann J; Olthoff K; Shaked A; Bloom RD; Reddy KR
Liver Transpl; 2008 May; 14(5):665-71. PubMed ID: 18433034
[TBL] [Abstract][Full Text] [Related]
25. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
[TBL] [Abstract][Full Text] [Related]
26. Effect of pretransplant hemoglobin blood level on kidney transplant outcome.
Abou-Jaoude MM; Nawfal N; Najm R; Shaheen J; Almawi WY
Exp Clin Transplant; 2009 Dec; 7(4):214-7. PubMed ID: 20353369
[TBL] [Abstract][Full Text] [Related]
27. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
[TBL] [Abstract][Full Text] [Related]
28. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
29. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Baron F; Frère P; Fillet G; Beguin Y
Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
[TBL] [Abstract][Full Text] [Related]
31. Value of serum cystatin C as a marker of renal function in the early post kidney transplant period.
Geramizadeh B; Azarpira N; Ayatollahi M; Rais-Jalali GA; Aghdai M; Yaghoobi R; Banihashemi M; Malekpour Z; Malek-Hosseini SA
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1015-7. PubMed ID: 19861863
[TBL] [Abstract][Full Text] [Related]
32. Time-dependent variations in urine output after renal transplantation.
Khosroshahi HT; Oskui R; Shoja MM; Tubbs RS; Ardalan MR
Transplant Proc; 2007 May; 39(4):932-3. PubMed ID: 17524854
[TBL] [Abstract][Full Text] [Related]
33. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
[TBL] [Abstract][Full Text] [Related]
34. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human erythropoietin in renal transplant recipients with renal anemia.
Traindl O; Barnas U; Franz M; Falger S; Klauser R; Kovarik J; Graf H
Clin Transplant; 1994 Feb; 8(1):45-8. PubMed ID: 8136567
[TBL] [Abstract][Full Text] [Related]
36. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
Gentil MA; Pérez-Valdivia MA; González-Roncero FM; López-Mendoza M; Cabello V; Bernal G; Suñer M; Pereira P
Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
[TBL] [Abstract][Full Text] [Related]
37. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin treatment in the sixth posttransplant month as a prognostic factor for renal allograft survival.
Molina P; Gavela E; Sancho A; Avila A; Fernández-Nájera JE; Beltrán S; Crespo JF; Pallardó LM
Transplant Proc; 2006 Oct; 38(8):2441-4. PubMed ID: 17097961
[TBL] [Abstract][Full Text] [Related]
39. Renal allograft failure after simultaneous pancreas-kidney transplantation: univariate and multivariate analyses of donor and recipient risk factors.
Douzdjian V; Rice JC; Carson RW; Gugliuzza KG; Fish JC
Clin Transplant; 1996 Jun; 10(3):271-7. PubMed ID: 8826665
[TBL] [Abstract][Full Text] [Related]
40. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
